FPLD3 (PPARγ mutation)Hepatic steatosis, hypertension, diabetes (HbA1c of 8%), hypertriglyceridemia (plasma TG at 2.55 mmol/L), hirsutism. This evidence concerns the gene PPARG and fatty liver disease.